NCT00508261 / 2006-006680-23: Co-Administration of Meningococcal Vaccine GSK134612 With Infanrix Hexa™ Versus Individual Administration of Each Vaccine |
|
|
| Completed | 3 | 793 | Europe | Meningococcal vaccine GSK134612, Infanrix™ hexa, Meningitec™ | GlaxoSmithKline | Infections, Meningococcal | 05/08 | 10/08 | | |
NCT01839175 / 2012-005547-24: Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination |
|
|
| Completed | 3 | 350 | Europe | Hexavalent vaccine, Diphtheria, tetanus, pertussis, hepatitis B,, poliomyelitis and Haemophilus influenzae type b conjugate vaccine (adsorbed)., NeisVac-C, Meningococcal group C polysaccharide conjugate vaccine adsorbed, Prevenar 13, Pneumococcal conjugate vaccine (13-valent, adsorbed), RotaTeq, Human-bovine rotavirus reassortants (live) vaccine, Nimenrix, Meningococcal group A, C, W-135 and Y conjugate vaccine, M-M-RVAXPRO, Measles, mumps and rubella vaccine (live) | Sanofi Pasteur, a Sanofi Company | Neisseria Meningitidis, Bacterial Infections, Virus Diseases | 07/14 | 02/15 | | |
